Logo image of ISRG

INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis

NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock

612.49  +8.37 (+1.39%)

Fundamental Rating

6

Taking everything into account, ISRG scores 6 out of 10 in our fundamental rating. ISRG was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is growing strongly while it is still valued neutral. This is a good combination! These ratings could make ISRG a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
In the past 5 years ISRG has always been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 12.64%, ISRG belongs to the top of the industry, outperforming 93.68% of the companies in the same industry.
ISRG has a Return On Equity of 14.39%. This is amongst the best in the industry. ISRG outperforms 89.47% of its industry peers.
ISRG's Return On Invested Capital of 11.36% is amongst the best of the industry. ISRG outperforms 92.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.08%.
Industry RankSector Rank
ROA 12.64%
ROE 14.39%
ROIC 11.36%
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With an excellent Profit Margin value of 28.51%, ISRG belongs to the best of the industry, outperforming 96.84% of the companies in the same industry.
ISRG's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 26.29%, ISRG belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
ISRG's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 66.98%, ISRG is doing good in the industry, outperforming 72.63% of the companies in the same industry.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 26.29%
PM (TTM) 28.51%
GM 66.98%
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ISRG is still creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
Compared to 5 years ago, ISRG has more shares outstanding
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

ISRG has an Altman-Z score of 61.45. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 61.45, ISRG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 61.45
ROIC/WACC1.23
WACC9.25%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 4.30 indicates that ISRG has no problem at all paying its short term obligations.
ISRG has a better Current ratio (4.30) than 73.16% of its industry peers.
A Quick Ratio of 3.42 indicates that ISRG has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.42, ISRG is doing good in the industry, outperforming 72.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 3.42
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.84% over the past year.
Measured over the past years, ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.97% on average per year.
Looking at the last year, ISRG shows a quite strong growth in Revenue. The Revenue has grown by 14.83% in the last year.
The Revenue has been growing by 13.85% on average over the past years. This is quite good.
EPS 1Y (TTM)25.84%
EPS 3Y19.06%
EPS 5Y8.97%
EPS Q2Q%26.03%
Revenue 1Y (TTM)14.83%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Sales Q2Q%16.88%

3.2 Future

ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.27% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.47% yearly.
EPS Next Y23.02%
EPS Next 2Y18.56%
EPS Next 3Y18.09%
EPS Next 5Y17.27%
Revenue Next Year14.92%
Revenue Next 2Y15.88%
Revenue Next 3Y15.86%
Revenue Next 5Y14.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 91.14, the valuation of ISRG can be described as expensive.
ISRG's Price/Earnings ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 65.79% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, ISRG is valued quite expensively.
ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 76.31.
67.37% of the companies in the same industry are more expensive than ISRG, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ISRG to the average of the S&P500 Index (24.44), we can say ISRG is valued expensively.
Industry RankSector Rank
PE 91.14
Fwd PE 76.31
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

64.21% of the companies in the same industry are more expensive than ISRG, based on the Enterprise Value to EBITDA ratio.
67.37% of the companies in the same industry are more expensive than ISRG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 372.28
EV/EBITDA 81.38
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 18.09% in the coming years.
PEG (NY)3.96
PEG (5Y)10.16
EPS Next 2Y18.56%
EPS Next 3Y18.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

NASDAQ:ISRG (1/22/2025, 2:43:48 PM)

612.49

+8.37 (+1.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-17 2024-10-17/amc
Earnings (Next)01-23 2025-01-23/amc
Inst Owners90.55%
Inst Owner Change-0.2%
Ins Owners0.5%
Ins Owner Change-2.54%
Market Cap218.16B
Analysts80.5
Price Target581.71 (-5.03%)
Short Float %1.24%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.88%
Min EPS beat(2)10.37%
Max EPS beat(2)13.38%
EPS beat(4)4
Avg EPS beat(4)8.48%
Min EPS beat(4)4.44%
Max EPS beat(4)13.38%
EPS beat(8)7
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)3.16%
EPS beat(16)13
Avg EPS beat(16)6.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)-0.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)0.12%
Revenue beat(8)2
Avg Revenue beat(8)-0.46%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)7
Avg Revenue beat(16)1.66%
PT rev (1m)4.46%
PT rev (3m)16.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.55%
EPS NY rev (1m)0%
EPS NY rev (3m)3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 91.14
Fwd PE 76.31
P/S 27.73
P/FCF 372.28
P/OCF 119.82
P/B 14
P/tB 14.34
EV/EBITDA 81.38
EPS(TTM)6.72
EY1.1%
EPS(NY)8.03
Fwd EY1.31%
FCF(TTM)1.65
FCFY0.27%
OCF(TTM)5.11
OCFY0.83%
SpS22.09
BVpS43.75
TBVpS42.7
PEG (NY)3.96
PEG (5Y)10.16
Profitability
Industry RankSector Rank
ROA 12.64%
ROE 14.39%
ROCE 12.87%
ROIC 11.36%
ROICexc 15.6%
ROICexgc 16.11%
OM 26.29%
PM (TTM) 28.51%
GM 66.98%
FCFM 7.45%
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
ROICexc(3y)19.34%
ROICexc(5y)19.83%
ROICexgc(3y)20.37%
ROICexgc(5y)21.16%
ROCE(3y)13.84%
ROCE(5y)13.55%
ROICexcg growth 3Y-1.89%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-0.57%
ROICexc growth 5Y-7.6%
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 247.98%
Cap/Sales 15.69%
Interest Coverage 250
Cash Conversion 70.95%
Profit Quality 26.12%
Current Ratio 4.3
Quick Ratio 3.42
Altman-Z 61.45
F-Score5
WACC9.25%
ROIC/WACC1.23
Cap/Depr(3y)158.69%
Cap/Depr(5y)157.89%
Cap/Sales(3y)9.9%
Cap/Sales(5y)9.4%
Profit Quality(3y)72%
Profit Quality(5y)81.76%
High Growth Momentum
Growth
EPS 1Y (TTM)25.84%
EPS 3Y19.06%
EPS 5Y8.97%
EPS Q2Q%26.03%
EPS Next Y23.02%
EPS Next 2Y18.56%
EPS Next 3Y18.09%
EPS Next 5Y17.27%
Revenue 1Y (TTM)14.83%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Sales Q2Q%16.88%
Revenue Next Year14.92%
Revenue Next 2Y15.88%
Revenue Next 3Y15.86%
Revenue Next 5Y14.47%
EBIT growth 1Y21.07%
EBIT growth 3Y18.66%
EBIT growth 5Y7.42%
EBIT Next Year41.2%
EBIT Next 3Y24.93%
EBIT Next 5Y22.48%
FCF growth 1Y-45.49%
FCF growth 3Y-13.13%
FCF growth 5Y-5.26%
OCF growth 1Y12.35%
OCF growth 3Y6.9%
OCF growth 5Y9.17%